Atezolizumab trials for Extensive-stage Small Cell Lung Cancer (ES-SCLC)

All Atezolizumab trials · All Extensive-stage Small Cell Lung Cancer (ES-SCLC) trials

Phase breakdown

Recruiting trials studying Atezolizumab for Extensive-stage Small Cell Lung Cancer (ES-SCLC)

• Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).
  NCT06663098 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 25 locations
• Iadademstat + SBRT With Atezo in ES-SCLC
  NCT07113691 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
  NCT07339059 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Atezolizumab for Extensive-stage Small Cell Lung Cancer (ES-SCLC)?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.